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Introduction and aim of the present work 
The number of patients suffering diabetes mellitus (DM) is increasing year-by-year 
and it has risen to approximately 250 million worldwide in 2007. DM is defined as a disease 
that results in chronic hyperglycemia due to an absolute or relative lack of insulin and/or 
insulin resistance that in turn impairs glucose, protein and lipid metabolism, and finally 
entrains the characteristic secondary complications. 
Trials for the use of vanadium in treating DM were first reported in 1899, which was 
23 years before the discovery of insulin. However, pharmaceutical interest in vanadium as an 
insulin substitute started in the 1980s. The insulin-like effects of vanadium compounds were 
proved by in vitro and in vivo studies. The main advantage of these compounds to insulin is 
that they may be administered orally. Accordingly, the aim of the research in this field is to 
make vanadium compounds which can reach the target cells with high efficacy. According to 
our present views, these compounds should have low molecular mass, should be neutral and 
should have optimal lipophilicity in order to be mobile and cross cell membranes easily. 
Most of vanadium's biologically important reactions occur in water-based 
environments such as blood plasma and intracellular fluids. Therefore the knowledge of the 
distribution and chemical speciation of the vanadium compounds in aqueous solution is of the 
utmost importance. It has to be taken into account that insulin-mimetic drugs will interact 
with numerous vanadofil exogenous or endogenous biomolecules during and after absorption. 
Via the redox and complexation reactions, the finely-tuned speciation of vanadium may lead 
to the efficiency of the metal to mimic the effects of insulin. 
The primary aims of the present work have been (i) to study the aqueous equilibrium 
of VIVO – potential carrier ligand systems and (ii) to model the interactions and actual 
chemical form of the vanadium in cells.  
Some carbohydrate and sal2en-type Schiff base derivatives have been selected as 
potential carrier ligands. The group of aldaric acids has been chosen, because they or their 
derivatives are produced naturally in small amounts by mammals, including humans, and the 
arrangement of the two carboxylic and the alcoholic donors is suitable for metal ion binding. 
The diastereomeric D-glucaric and galactaric acids have been characterized. The other group, 
the sal2en-type molecules present versatile steric, electronic and lipophilic properties. They 
may be easily prepared by the condensation of two compounds: (i) an aromatic  
o-hydroxyaldehyde and (ii) a diamine; the hydrophilic–lipophilic balance being easily fine-
tuned by choosing the appropriate amine precursors and ring substituents of the aldehyde. The 
reduction of imine groups of the Schiff bases to amine groups gives beneficial properties to 
the sal2en derivatives. The pyridoxal-containing pyr2en and rpyr2en, and the asymmetric 
sal2dpa and sal2orn bearing a pendant carboxylate group have been studied. 
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In order to assess the molecular form of vanadium insulin-mimetic complexes in cells, 
the interactions in the model systems of VIVO-maltol and VIVO-dipicolinic acid with various 
vanadofil cell components ATP and GSH also have been studied. 
 Accordingly, the solution speciation and the binding modes of the VIVO complexes of 
selected ligands have been investigated and discussed in the dissertation. pH-potentiometry 
has been used to determine the stoichiometry and stability constants of the complexes formed, 
and spectroscopic (UV-VIS, CD and EPR) measurements have been made to establish the 
most probable structures of the complexes present in aqueous solution. 
 
 
Experimental methods  
Solution equilibria, speciation and composition of species formed have been 
determined by pH-potentiometric titrations. Reactions causing some pH-effect can be 
investigated by this method. All measurements have been carried out in aqueous solution, at 
constant temperature (25.0 ± 0.1 oC) and ionic strength (I = 0.20 M, KCl), under inert 
atmosphere (Ar). Experimental data have been evaluated by SUPERQUAD and PSEQUAD 
computer programs. 
The complex formation has been followed in all system by UV-Vis 
spectrophotometry. The evaluation of electronic absorption spectra gives some information 
about the number and the quality of the coordinating donor atoms and the geometry of the 
complex formed.  
Circular Dichroism spectroscopy (CD) is a very powerful technique to study optically 
active molecules. Circular dichroism or Cotton-effect is based on the differential absorption of 
left- and right-handed circularly polarized light in optically active medium. CD spectra in the 
visible light region are only produced when a metal ion is in a chiral environment. Optical 
activity in metal ion complexes has been attribute to configurational, conformational and the 
vicinal effects. This method has been used for characterizing the complexes formed in the 
VIVO–sal2-L-dpa system and for detecting some ternary complex formation with ATP or 
GSH. 
Electron Paramagnetic Resonance (EPR) spectroscopy is a technique to study 
paramagnetic ions or molecules. The oxovanadium(IV) ion has one unpaired electron  
(S = 1/2), while the isotope 51V (its natural abundance is 99.76%) has a nuclear spin of 7/2; 
thus, the isotropic spectra obtained at room temperature consist of eight lines, while in frozen 
solutions VIVO complexes of tetragonal symmetry display eight parallel and eight 
perpendicular lines. The EPR parameters of the complexes have been obtained by simulation 
of the spectra with the aid of the computer program of A. Rockenbauer and L. Korecz. These 
data have been used to establish the most probable binding mode of the complexes formed. 
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Structure of the ligands studied 
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New scientific results 
1. Oxovanadium(IV) complexes of selected aldaric acids (D-glucaric and galactaric acids) 
1.1. Both of the aldaric acids studied proved to be fairly strong vanadium binders in the 
weakly acidic and neutral pH range. At basic pH, the ligand molecules are partly 
displaced by OH−. Accordingly of the stability of their complexes, they might 
promote the absorption of the vanadium as carrier ligands. 
1.2. At low pH, complex formation starts at the terminal COO− functions and probably the 
adjacent alcoholic-OH groups strengthen the interactions between the metal ion and 
the ligand. Then the alcoholic-OH group in the coordination sphere deprotonates. 
This metal-induced process becomes complete with appearance of the dinuclear or 
dimer complexes. The dimerization is endothermic and entropy governed. An 
interesting cis–trans isomeric equilibrium characteristic for the α-hydroxycarboxylic 
acids has been assumed and analyzed by EPR and molecular modeling. 
1.3. These chiral ligands do not exhibit stereoselectivity in protonation reactions; 
meanwhile for the formation of dinuclear complexes the opposite has been 
established. According to the pH-potentiometric and EPR investigations the 
D-glucaric acid is a somewhat more efficient VIVO binder than the galactaric acid. 
 
2. Oxovanadium(IV) complexes of pyr2en: N,N’-ethylene-bis(pyridoximine) and rpyr2en: 
N,N’-ethylene-bis(pyridoxamine) 
2.1. Both pyr2en and rpyr2en have been found to form basically similar 1:1 complexes 
([VOLHn]n+; n = 2, 1, 0), the tetradentate coordination of the ligands through two 
phenolate-O and two amine/imine-N being the predominant binding mode. The 
pyridinium-N atoms of the pyridoxal rings do not take part in the coordination but are 
involved in acid-base reactions.  
2.2. The neutral [VOL] complex is hardly soluble in water, precipitations of these 
compounds occur during the pH-potentiometric titrations if their concentrations are in 
the mM range. The neutral complex of the pyr2en is less soluble. 
2.3. The solution speciation revealed that the rpyr2en forms more stable complexes with 
VIVO than the pyr2en itself. This difference in the stability may probably be explained 
by the much higher flexibility of the reduced Schiff base ligand, lacking the –C=N– 
double bonds, thus resulting in significantly less strain and/or better ligand-metal 
orbital overlap in the complexes formed. At low pH, the pyr2en forms [VOLH4]4+ 
complex first, only the half of the molecule coordinates through a phenolate-O and an 
imine-N. The pyr2en ligand itself may also hydrolyze as other Schiff bases.  
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2.4. EPR studies indicate the presence of various isomeric species in the solution of the 
VIVO – rpyr2en system. An interesting cis–trans isomeric equilibrium has been 
assumed and analyzed by EPR and molecular modeling for the [VOLHn]n+  
complexes. 
2.5. Upon comparison with the VIVO –, ZnII –, NiII – and CuII – rpyr2en systems, the 
proton displacement constants of the [MLHn]n+ complexes give the stability order 
CuII > VIVO > NiII > ZnII. 
 
3. Oxovanadium(IV) complexes of sal2dpa: N,N’-bis(2-hydroxybenzyl)-2,3-diamino-
propionic acid and sal2orn: N,N’-bis(2-hydroxybenzyl)-2,5-diamino-pentanoic acid 
3.1. Both ligands form stable and differently protonated basically 1:1 complexes with 
VIVO ion in aqueous solution. The sal2dpa and the sal2orn proved to be efficient 
vanadium binder between pH 5–9 and 7–10, respectively, the [VOL]– is the only 
species in these pH ranges. 
3.2. The sal2dpa proved to be more efficient VIVO chelator than the sal2orn, the 
arrangement of its donor atoms is more suitable for metal ion binding. We have 
highlighted the differences in the binding abilities of this pentatdentate sal2dpa and 
other water soluble but tetradentate sal2en derivative (R(SO3-sal)2en), coordination of 
the extra carboxylate group increases the stability of the complexes.  
3.3. At low pH only the half of the molecules is coordinated tridentately, then two other 
donor groups deprotonate cooperatively and coordinate to the metal centre. EPR 
studies indicate the presence of various isomeric species in the solution of the  
VIVO – sal2dpa system. 
 
4. Interactions of insulin-mimetic oxovanadium(IV) complexes with the cell constituents ATP 
and GSH 
4.1. Although both cell constituents form some ternary complexes in the model systems 
studied, the results suggest that GSH mostly takes part in redox reactions of vanadium 
and ATP, as a strong VIVO binder, chelates the metal ion, forming binary and/or 
ternary complexes. 
4.2. ATP coordinates to VIVO centre through the phosphate moiety in the VOAB ternary 
complexes formed in the acidic and neutral pH range, and through the ribose residue 
in the VOABH–2 complexes formed in basic solutions. At the physiological pH the 
VIVO ion rather forms biscomplex with maltol than ternary complexes with maltol 
and ATP. According to the speciation studies, in the solution of the VIVO–dipicolinic 
acid – ATP system ternary complexes dominate between pH 4–9. The dipicolinic acid 
and the ATP bind more efficiently the vanadium together than separately. 
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4.3. Ternary complex formation with GSH has been detected only by EPR measurements 
at a relatively high excess of GSH. The lower excess of GSH applied in the pH-
potentiometric titrations has not been enough to prevent the partial hydrolysis of the 
metal ion. In the ternary complexes of GSH, it most probably coordinates at the Gly 
end through (COO–, amide-O or H2O) donors and the participation of the S donor in 
the metal binding is possible above pH 7. 
4.4. The results of this work strongly suggest that ATP binds relevant VIVO species under 
cellular conditions and thus might somehow be involved in the insulin-mimetic action 
of VIVO compounds. The time course of the parallel redox and complexation reaction 
needs further investigation. 
 
 
 
Publications related to the subject of the dissertation 
1. Á. Dörnyei, E. Garribba, T. Jakusch, P. Forgó, G. Micera, T. Kiss: 
Vanadium(IV,V) complexes of D-saccharic and mucic acids in aqueous solution 
Dalton Trans. 2004, 12, 1882–1891. IF: 2.926 
2. I. Correia, J. Costa Pessoa, M. T. Duarte, R. T. Henriques, M. F. M. Piedade, L. F. Veiros, 
T. Jakusch, T. Kiss, Á. Dörnyei, M. M. C. A. Castro, C. F. G. C. Geraldes, F. Avecilla: 
N,N’-ethylenebis(pyridoxylideneiminato) and N,N’-ethylenebis(pyridoxylaminato): 
synthesis, characterization, potentiometric, spectroscopic and DFT studies of their 
vanadium(IV) and vanadium(V) complexes 
Chem.-A Eur. J. 2004, 10, 2301–2317. IF: 4.517 
3. J. Costa Pessoa, S. Marcão, I. Correia, G. Gonçalves, A. Dörnyei, T. Kiss, T. Jakusch, 
I. Tomaz, M. M. C. A. Castro, C. F. G. C. Geraldes, F. Avecilla: 
Vanadium (IV and V) complexes of reduced Schiff bases derived from the reaction of 
aromatic o-hydroxyaldehydes and diamines containing carboxylic groups 
Eur. J. Inorg. Chem. 2006, 18, 3595–3606. IF: 2.704 
4. Á. Dörnyei, S. Marcão, J. Costa Pessoa, T. Jakusch, T. Kiss: 
Interactions of insulin-mimetic vanadium complexes with the cell constituents ATP and 
glutathione 
Eur. J. Inorg. Chem. 2006, 18, 3614–3621. IF: 2.704 
 ΣIF: 12.851 
 
 7
Other publications 
1. T. Jakusch, Á. Dörnyei, I. Correia, L. M. Rodrigues, G. K. Tóth, T. Kiss, J. Costa Pessoa, 
S. Marcão: 
Interaction of VIVO, VVO2 and CuII with a Peptide Analogue SalGly-L-Ala 
Eur. J. Inorg. Chem. 2003, 11, 2113–2122. IF: 2.482 
2. Á. Dörnyei, M. Kilyén, T. Kiss, B. Gyurcsik, I. Laczkó, A. Pécsváradi, M. L. Simon, 
M. Kotormán: 
The effects of Al(III) speciation on activity of trypsin 
J. Inorg. Biochem. 2003, 97, 118–123. IF: 2.343 
3. Á. Dörnyei, I. G. Csizmadia: 
An exploratory study of the conformational intricacy of selected fluoro-substituted 
carboxylic acids 
J. Mol. Struc.-Theochem 2003, 666–667, 135–141. IF: 1.027 
4. I. Correia, A. Dornyei, F. Avecilla, T. Kiss, J. Costa Pessoa: 
X-ray crystal structure and characterization in aqueous solution of 
{N,N’-ethylenebis(pyridoxylaminato)}zinc(II) 
Eur. J. Inorg. Chem. 2006, 3, 656–662. IF: 2.704 
5. I. Correia, A. Dornyei, T. Jakusch, F. Avecilla, T. Kiss, J. Costa Pessoa: 
Water-soluble sal2en- and reduced sal2en-type ligands: study of their CuII and NiII 
complexes in the solid state and in solution 
Eur. J. Inorg. Chem. 2006, 14, 2819–2830. IF: 2.704 
6. T. Kiss, T. Jakusch, D. Hollender, Á. Dörnyei: 
Biospeciation of insulin-mimetic VO(IV) complexes 
ACS Symposium Series 974, Vanadium: The Versatile Metal, Editors: K. Kustin, J. Costa 
Pessoa, D. C. Crans, 2007, 323–339. 
7. T. Kiss, T. Jakusch, D. Hollender, Á. Dörnyei, É. A. Enyedy, J. Costa Pessoa, H. Sakurai, 
A Sanz-Medel: 
Biospeciation of insulin-mimetic VO(IV) complexes 
Coord. Chem. Rev. 2008, xx, xxx–xxx. (accepted for publication) IF: 8.815 
 ΣIF: 20.075 
 
Oral (o) and poster (p) presentations 
1. Á. Dörnyei, M. Kilyén, T. Kiss, B. Gyurcsik, I. Laczkó, A. Pécsváradi, M. L. Simon, 
M. Kotormán: 
The effects of Al(III) speciation on activity of trypsin (p) 
Fifth Keele Meeting on Aluminium; Aluminium in Life: From Acid Rain to Alzheimer's 
Disease, 23–25 February, 2003, Keele, UK 
2. Á. Dörnyei, M. Kilyén, T. Kiss, B. Gyurcsik, I. Laczkó, A. Pécsváradi, M. L. Simon, 
M. Kotormán: 
The effects of Al(III) speciation on activity of trypsin – 2. Similarity searches (o) 
The Vth International Symposium – Young People and Multidisciplinary Research, 6–7 
November, 2003, Timisoara, Romania 
 8
3. Dörnyei Á., E. Garribba, Jakusch T., Forgó P., Kiss T.: 
A D-cukorsav és a nyálkasav vanádiumkötő sajátságai (o) 
XXXVIII. Komplexkémiai Kollokvium, 21–23 May, 2003, Gyula 
4. Á. Dörnyei, G. Paragi, I.G. Csizmadia: 
An exploratory study of the conformational intricacy of selected fluoro-substituted 
carboxylic acids (p) 
“The role of chemistry in the evolution of molecular medicine” A tribute to Professor 
Albert Szent-Györgyi, 27–29 June, 2003, Szeged 
5. Dörnyei Á., E. Garribba, Jakusch T., Forgó P., G. Micera és Kiss T.: 
Aldársavak oxovanádium(IV)- és vanádium(V)-komplexei vizes oldatban (o) 
XXVI. Kémiai Előadói Napok, 27–29 October, 2003, Szeged 
6. Dörnyei Á., Kilyén M., Gyurcsik B., Laczkó I., L. Simon M., Kotormán M., Pécsváradi A., 
Kiss T.: 
Al(III)-komplexek hatása a szerin-proteáz tripszinre (o) 
XXXIX. Komplexkémiai Kollokvium, 26–28 May, 2004, Gárdony 
7. Á. Dörnyei, T. Jakusch, P. Forgó, E. Garribba, G. Micera, T. Kiss: 
VO(IV)- and VO2(V)-binding abilities of saccharic and mucic acids (o) 
3rd Working-group meeting (Insulin-mimetic vanadium compounds, COST D21/009/01), 
September 6–7, 2004, Szeged 
8. Á. Dörnyei, S. Marcão, J. Costa Pessoa, T. Kiss: 
Complexation in the ternary systems of VO(IV)-dipicolinate and VO(IV)-maltolate with 
ATP and glutathione: a model for cell processes (o) 
4th Working–group meeting (Insulin–Mimetic Vanadium Compounds, COST D21/009/01), 
October 1–2, 2005, Thessaloniki, Greece 
9. T. Kiss, Á. Dörnyei, S. Bouhsina, S. Marcão, J. Costa Pessoa: 
Interactions of insulin mimetic vanadium complexes with cell constituents: ATP and 
glutathione (p) 
First European Conference on Chemistry for Life Sciences, October 4–8, 2005, Rimini, 
Italy 
10. Dörnyei Á., S. Marcão, J. Costa Pessoa, Kiss T.: 
Inzulinutánzó oxovanádium(IV)komplexek kölcsönhatása sejtalkotó bioligandumokkal (o) 
XLI. Komplexkémiai Kollokvium, 31 May – 2 June, 2006, Mátrafüred 
11. T. Kiss, T. Jakusch, D. Hollender, Á. Dörnyei: 
Biospeciation of insulin-mimetic VO(IV) complexes (o) 
The Fifth International Symposium on the Chemistry and Biological Chemistry of 
Vanadium, September 10–14, 2006, San Francisco, California, USA 
12. Á. Dörnyei, T. Kiss, S. Marcão, J. Costa Pessoa: 
Interactions of insulin mimetic vanadium complexes with cell constituents: ATP and 
glutathione (p) 
The Fifth International Symposium on the Chemistry and Biological Chemistry of 
Vanadium, September 10–14, 2006, San Francisco, California, USA 
 
 9
13. J. Costa Pessoa, S. Marcão, I. Correia, G. Gonçalves, A. Dörnyei, T. Kiss, T. Jakusch, 
I. Tomaz, M.M.C.A. Castro, C.F.G.C. Geraldes, F. Avecilla: 
Vanadium (IV and V) complexes of reduced Schiff bases derived from the reaction of 
aromatic o-hydroxyaldehydes and diamines containing carboxylic groups (p) 
The Fifth International Symposium on the Chemistry and Biological Chemistry of 
Vanadium, September 10–14, 2006, San Francisco, California, USA 
14. Á. Dörnyei, S. Marcão, J. Costa Pessoa, T. Jakusch, T. Kiss: 
Interactions of insulin-mimetic vanadium complexes with the cell constituents ATP and 
glutathione (p) 
2nd European Conference on Chemistry for Life Sciences, 
September 4-8, 2007, Wroclaw, Poland 
